A Randomized, Double Blind, Placebo Controlled, Multicentric Study to Assess the Efficacy and Safety of Udenafil Tablets in Patients Suffering From Erectile Dysfunction.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2013
At a glance
- Drugs Udenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Abdi Ibrahim Pharmaceuticals
- 11 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2012 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 11 May 2012 Actual patient number is 118 according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History